What The Study Did: Researchers examined whether Medicaid patients in Wisconsin with opioid use disorder experienced decreased access to treatment, including receiving buprenorphine and urine drug testing during the COVID-19 pandemic.
Authors: Alyssa Shell Tilhou, M.D., Ph.D., of the Boston University School of Medicine/Boston Medical Center, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2022.0093)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.0093?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031122
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Journal
JAMA Health Forum